Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · IEX Real-Time Price · USD
4.430
+0.030 (0.68%)
Jul 22, 2024, 10:23 AM EDT - Market open
Shattuck Labs Employees
Shattuck Labs had 75 employees as of December 31, 2023. The number of employees decreased by 30 or -28.57% compared to the previous year.
Employees
75
Change (1Y)
-30
Growth (1Y)
-28.57%
Revenue / Employee
$36,200
Profits / Employee
-$1,134,373
Market Cap
210.17M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 75 | -30 | -28.57% |
Dec 31, 2022 | 105 | 20 | 23.53% |
Dec 31, 2021 | 85 | 26 | 44.07% |
Dec 31, 2020 | 59 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Inogen | 834 |
The Joint | 794 |
bluebird bio | 323 |
Biodesix | 217 |
Century Therapeutics | 165 |
Genfit | 159 |
Caribou Biosciences | 158 |
Actinium Pharmaceuticals | 49 |
STTK News
- 21 days ago - Shattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 5 weeks ago - Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leuk - GlobeNewsWire
- 6 weeks ago - Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML) - GlobeNewsWire
- 6 weeks ago - Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk My - GlobeNewsWire
- 2 months ago - Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the E - GlobeNewsWire
- 2 months ago - Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 months ago - Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024 - GlobeNewsWire
- 4 months ago - Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire